Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166,728 | 51,704 | 81,309 | 28,451 | 68,520 |
| Marketable Securities | 126,146 | 63,191 | 84,475 | N/A | N/A |
| Receivables | 33,608 | 19,660 | 17,280 | 18,320 | 25,423 |
| Inventories | 40,737 | 20,533 | 21,473 | 20,825 | 19,689 |
| TOTAL | $375,880 | $158,215 | $208,815 | $72,066 | $117,663 |
| Non-Current Assets | |||||
| PPE Net | 42,556 | 24,187 | 25,652 | 28,034 | 17,531 |
| Intangibles | 140,251 | 107,717 | 118,851 | 134,306 | 146,769 |
| Other Non-Current Assets | 53,657 | 32,948 | 36,992 | 40,808 | 42,794 |
| TOTAL | $236,464 | $164,852 | $181,495 | $203,148 | $207,094 |
| Total Assets | $612,344 | $323,067 | $390,310 | $275,214 | $324,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 5,000 | 2,083 | 6,838 | N/A |
| Accounts payable and accrued liabilities | 12,282 | 9,236 | 7,914 | 10,602 | 9,220 |
| Accrued Expenses | 30,739 | 21,019 | 9,153 | 4,920 | 13,787 |
| TOTAL | $65,894 | $109,327 | $43,443 | $49,568 | $54,249 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 3,414 | 8,194 | 10,049 | N/A |
| Deferred Revenues | 16,645 | 15,219 | 14,436 | 15,482 | 16,387 |
| Other Non-Current Liabilities | 33,730 | 32,008 | 89,657 | 92,590 | 93,735 |
| TOTAL | $74,728 | $50,538 | $117,081 | $131,050 | $131,458 |
| Total Liabilities | $140,622 | $159,865 | $160,524 | $180,618 | $185,707 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 378,986 | 290,118 | 79,064 | 77,199 | 74,547 |
| Common Shares | 396 | 83 | 80 | 77 | 75 |
| Retained earnings | -1,185,651 | -1,000,752 | -926,096 | -735,998 | -676,761 |
| Other shareholders' equity | 758 | 309,055 | 309,794 | -907 | 112 |
| TOTAL | $471,722 | $163,202 | $229,786 | $94,596 | $139,050 |
| Total Liabilities And Equity | $612,344 | $323,067 | $390,310 | $275,214 | $324,757 |